Microsoft Dragon Copilot vs Tempus AI
A detailed comparison to help you choose between Microsoft Dragon Copilot and Tempus AI.
🏆
Verdict: Tempus AI wins
Tempus AI scores 4.1/5, edging out Microsoft Dragon Copilot at 3.8/5. Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.
Microsoft Dragon Copilot Microsoft AI ambient clinical intelligence | Tempus AI AI for precision medicine and clinical genomics | |
|---|---|---|
| Rating | 3.8 (1 review) | 4.1 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $500/mo | From $1000/mo |
| Best For | Large health systems and hospital groups on Epic or Cerner that want the deepest ambient documentation platform available and can support an enterprise clinical rollout. | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | ssoteam features | ssoteam features |
| Visit Microsoft Dragon Copilot → | Visit Tempus AI → |
Microsoft Dragon Copilot
Pros
- + Role-based workflows go beyond physician scribing — nursing flowsheet capture via Epic Rover and a radiology companion for PowerScribe One
- + Drafts in the samples I reviewed needed less cleanup than earlier DAX output, especially assessment-and-plan structuring and dictated medical vocabulary
- + Mature EHR integration: notes land inside the Epic charting workflow rather than a side panel, per implementation references I checked
- + Flex licensing lets low-volume clinicians pay per ambient note instead of a flat enterprise seat
- + May 2026 price restructuring cut the unlimited Per User tier 57% (from $3,528 to $1,512/user/month per partner deployment guides) and Microsoft now lists tiers on its commercial marketplace
Cons
- - No public rate card or self-serve trial on the vendor page — every price figure circulating is reseller or partner material, and the one visible license ($150–160/user/month Physician Practice) hit end-of-sale on 1 May 2026
- - Flex consumption adds up fast: about $3 per ambient note at published rates, roughly $60/day for a 20-encounter clinician
- - Multi-party conversations can attribute findings to the wrong speaker in my review of draft notes — a trust-damaging error type
- - Typical implementations run three to six months with one- to three-year contracts; not viable for small practices
- - Reported savings (about 7 minutes per encounter) are partner marketing figures — demand pilot metrics for your own encounter mix
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
Frequently Asked Questions
Which is better, Microsoft Dragon Copilot or Tempus AI?▼
Tempus AI scores higher at 4.1/5 vs 3.8/5 for Microsoft Dragon Copilot, making it the better-rated option in our comparison.
What is the difference between Microsoft Dragon Copilot and Tempus AI?▼
Microsoft Dragon Copilot: Microsoft Dragon Copilot is an AI clinical assistant that streamlines clinical documentation and automates healthcare workflows so clinicians can spend more time on patient care. Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties.
Is Microsoft Dragon Copilot or Tempus AI more affordable?▼
Microsoft Dragon Copilot starts at €500/mo, Tempus AI starts at €1000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.